Candesartan32mg

DRUG2 trials

Sponsors

HanAll BioPharma Co., Ltd., Alvogen Korea

Conditions

CholesterolemiaHypertension

Phase 1

Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg

CompletedNCT01806311

HanAll BioPharma Co., Ltd.Hypertension

Start: 2012-12-31End: 2013-08-31Updated: 2025-04-20

Phase 3

Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy

CompletedNCT02770261

Alvogen KoreaCholesterolemia, Hypertension

Start: 2015-12-31End: 2016-10-31Updated: 2016-12-26

Related Papers

Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study.

2019-07-1210 citations